The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Japanese Subjects With Chronic Heart Failure
The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Japanese Subjects With Chronic Heart Failure
A study to compare the efficacy and safety of eplerenone in Japanese chronic heart failure patients with placebo.
The aim of this study was to show consistency with the EMPHASIS-HF trial (NCT00232180), which was defined as a HR of the primary endpoint of below 1.
Inclusion Criteria:
Exclusion Criteria:
Matuyama-shi, Ehime 790-0024, Japan
Iizuka-shi, Fukuoka 820-8505, Japan
Kurume-shi, Fukuoka 830-0011, Japan
Kōriyama, Fukushima 963-8052, Japan
Hakodate-shi, Hokkai-do 041-8512, Japan
Toride-shi, Ibaraki 302-0022, Japan
Sakai-shi, Osaka 593-8304, Japan
Suita-shi, Osaka 565-8565, Japan
Yodogawa-ku, Osaka 532-0003, Japan
Kasukabe-shi, Saitama 344-0035, Japan
Saitama-shi, Saitama 330-0834, Japan
Kusatsu-shi, Shiga 525-8585, Japan
Shimotsuke-shi, Tochigi 329-0498, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Chiyoda-Ku, Tokyo 101-8643, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Yonago-shi, Tottori 683-8504, Japan
Takasaki-shi, 370-0829, Japan